Abu Ghazaleh, H., Hashem, R., Forbes, A., Dilwayo, T. R., Duaso, M., Sturt, J., Halson-Brown, S., & Mulnier, H. (2018). A systematic review of ultrasound-detected lipohypertrophy in insulin-exposed people with diabetes. Diabetes Therapy, 9(5), 1741-1756. https://doi.org/10.1007/s13300-018-0472-7
Agresti, A. (2013). Categorical data analysis (3rd ed.). Hoboken, NJ: John Wiley & Sons.
Al Hayek, A. A., Robert, A. A., Braham, R. B., & Al Dawish, M. A. (2016). Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: A cross-sectional study. Diabetes Therapy, 7(2), 259-267. https://doi.org/10.1007/s13300-016-0161-3
AlJaber, A. N., Sales, I., Almigbal, T. H., Wajid, S., & Batais, M. A. (2020). The prevalence of lipohypertrophy and its associated factors among Saudi patients with type 2 diabetes mellitus. Journal of Taibah University Medical Sciences, 15(3), 224-231. https://doi.org/10.1016/j.jtumed.2020.03.006
Arora, S., Agrawal, N. K., Shanthaiah, D. M., Verma, A., Singh, S., Patne, S. C. U., Kalra, S., Singh, P., & Goyal, S. (2021). Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Primary Care Diabetes, 15(5), 859-864. https://doi.org/10.1016/j.pcd.2021.06.004
Barola, A., Tiwari, P., Bhansali, A., Grover, S., & Dayal, D. (2018). Insulin-related lipohypertrophy: Lipogenic action or tissue trauma? Frontiers in Endocrinology, 9, 638. https://doi.org/10.3389/fendo.2018.00638
Benson, E.-o. N., Okeke, N. T., & Okeke, C. B. (2017). Factors that influence insulin adherence in self-administration and actions that could improve it. Journal of Nursing and Palliative Care Services, 1(1), 16-22.
Blanco, M., Hernández, M. T., Strauss, K. W., & Amaya, M. (2013). Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metabolism, 39(5), 445-453. https://doi.org/10.1016/j.diabet.2013.05.006
Buyruk, B. A., Kebapci, N., Yorulmaz, G., Alaguney, E. S., Akalin, A., & Efe, B. (2019). 59-LB: Prevalence and risk factors of lipohypertrophy and lipoatrophy in diabetes patients receiving insulin therapy. Diabetes, 68(Supplement_1). https://doi.org/10.2337/db19-59-LB
Calliari, L. E., Cudizio, L., Tschiedel, B., Pedrosa, H. C., Rea, R., Pimazoni-Netto, A., Hirsch, L., & Strauss, K. (2018). Insulin Injection Technique Questionnaire: Results of an international study comparing Brazil, Latin America and World data. Diabetology & Metabolic Syndrome, 10(1), 1-7. https://doi.org/10.1186/s13098-018-0389-3
Cunningham, M. T., & McKenna, M. (2013). Lipohypertrophy in insulin-treated diabetes: Prevalence and associated risk factors. Journal of Diabetes Nursing, 17(9), 340-343.
De Coninck, C., Frid, A., Gaspar, R., Hicks, D., Hirsch, L., Kreugel, G., Liersch, J., Letondeur, C., Sauvanet, J. P., & Tubiana, N. (2010). Results and analysis of the 2008–2009 Insulin Injection Technique Questionnaire survey. Journal of Diabetes, 2(3), 168-179. https://doi.org/10.1111/j.1753-0407.2010.00077.x
Deng, N., Zhang, X., Zhao, F., Wang, Y., & He, H. (2018). Prevalence of lipohypertrophy in insulin‐treated diabetes patients: A systematic review and meta‐analysis. Journal of Diabetes Investigation, 9(3), 536-543. https://doi.org/10.1111/jdi.12742
Eroglu, N., & Sabuncu, N. (2021). The effect of education given to type 2 diabetic individuals on diabetes self-management and self-efficacy: Randomized controlled trial. Primary Care Diabetes, 15(3), 451-458. https://doi.org/10.1016/j.pcd.2021.02.011
Famulla, S., Hövelmann, U., Fischer, A., Coester, H.-V., Hermanski, L., Kaltheuner, M., Kaltheuner, L., Heinemann, L., Heise, T., & Hirsch, L. (2016). Insulin injection into lipohypertrophic tissue: Blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diabetes Care, 39(9), 1486-1492. https://doi.org/10.2337/dc16-0610
Gentile, S., Guarino, G., Giancaterini, A., Guida, P., & Strollo, F. (2016). A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. Springerplus, 5(1), 1-7. https://doi.org/10.1186/s40064-016-1978-y
Gentile, S., Strollo, F., Viazzi, F., Russo, G., Piscitelli, P., Ceriello, A., Giorda, C., Guida, P., Fioretto, P., & Pontremoli, R. (2018). Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions. Journal of Diabetes Research, 2018, 7153087. https://doi.org/10.1155/2018/7153087
Gerensea, H., Moges, A., Shumiyee, B., Abrha, F., Yesuf, M., Birihan, T., Birhanu, T., & Getahun, Z. (2015). Knowledge and attitude on insulin self administration among type one diabetic patients in Mekele hospital, Tigray, Ethiopia. Advances in Surgical Sciences, 3(5), 32-36. https://doi.org/10.11648/j.ass.20150305.11
Gorska-Ciebiada, M., Masierek, M., & Ciebiada, M. (2020). Improved insulin injection technique, treatment satisfaction and glycemic control: Results from a large cohort education study. Journal of Clinical & Translational Endocrinology, 19, 100217. https://doi.org/10.1016/j.jcte.2020.100217
Gunawan, J., Marzilli, C., & Aungsuroch, Y. (2021). Establishing appropriate sample size for developing and validating a questionnaire in nursing research. Belitung Nursing Journal, 7(5), 356-360. https://doi.org/10.33546/bnj.1927
Hajheydari, Z., Kashi, Z., Akha, O., & Akbarzadeh, S. (2011). Frequency of lipodystrophy induced by recombinant human insulin. European Review for Medical and Pharmacological Sciences, 15(10), 1196-1201.
Ji, L., Sun, Z., Li, Q., Qin, G., Wei, Z., Liu, J., Chandran, A. B., & Hirsch, L. J. (2017). Lipohypertrophy in China: Prevalence, risk factors, insulin consumption, and clinical impact. Diabetes Technology & Therapeutics, 19(1), 61-67. https://doi.org/10.1089/dia.2016.0334
Kadiyala, P., Walton, S., & Sathyapalan, T. (2014). Insulin induced lipodystrophy. British Journal of Diabetes, 14(4), 131-133. https://doi.org/10.15277/bjdvd.2014.036
Kaiser, H. F. (1974). An index of factorial simplicity. Psychometrika, 39(1), 31-36. https://doi.org/10.1007/BF02291575
Kalra, S., Kumar, A., & Gupta, Y. (2016). Prevention of lipohypertrophy. Journal of the Pakistan Medical Association, 66(7), 910-911.
Lim, L.-L., Lau, E. S. H., Fu, A. W. C., Ray, S., Hung, Y.-J., Tan, A. T. B., Chamnan, P., Sheu, W. H. H., Chawla, M. S., & Chia, Y.-C. (2021). Effects of a technology-assisted integrated diabetes care program on cardiometabolic risk factors among patients with type 2 diabetes in the Asia-Pacific region: the JADE program randomized clinical trial. JAMA Network Open, 4(4), e217557-e217557. https://doi.org/10.1001/jamanetworkopen.2021.7557
Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.
Omar, M. A., El-Kafoury, A. A., & El-Araby, R. I. (2011). Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors. BMC Research Notes, 4(1), 1-3. https://doi.org/10.1186/1756-0500-4-290
Pahuja, V., Punjot, P., Fernandes, G., & Chatterjee, N. (2019). Exploring the factors associated with lipohypertrophy in insulin-treated type 2 diabetes patients in a tertiary care hospital in Mumbai, India. International Journal of Diabetes in Developing Countries, 39(3), 426-431. https://doi.org/10.1007/s13410-019-00735-0
Pozzuoli, G. M., Laudato, M., Barone, M., Crisci, F., & Pozzuoli, B. (2018). Errors in insulin treatment management and risk of lipohypertrophy. Acta Diabetologica, 55(1), 67-73. https://doi.org/10.1007/s00592-017-1066-y
Rahim, F. F., Abdulrahman, S. A., Kader Maideen, S. F., & Rashid, A. (2020). Prevalence and factors associated with prediabetes and diabetes in fishing communities in penang, Malaysia: A cross-sectional study. PloS One, 15(2), e0228570. https://doi.org/10.1371/journal.pone.0228570
Spollett, G., Edelman, S. V., Mehner, P., Walter, C., & Penfornis, A. (2016). Improvement of insulin injection technique: Examination of current issues and recommendations. The Diabetes Educator, 42(4), 379-394. https://doi.org/10.1177/0145721716648017
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., & Mbanya, J. C. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
Tee, E., & Yap, R. W. K. (2017). Type 2 diabetes mellitus in Malaysia: Current trends and risk factors. European Journal of Clinical Nutrition, 71(7), 844-849. https://doi.org/10.1038/ejcn.2017.44
Vardar, B., & Kızılcı, S. (2007). Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Research and Clinical Practice, 77(2), 231-236. https://doi.org/10.1016/j.diabres.2006.12.023
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2014). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. International Journal of Surgery, 12(12), 1495-1499. https://doi.org/10.1016/j.ijsu.2014.07.013
Wang, K., Zhang, S., Liu, C., & Chen, Y. (2021). A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy. Therapies, 76(6), 617-628. https://doi.org/10.1016/j.therap.2021.04.002
Watson, R., & Thompson, D. R. (2006). Use of factor analysis in Journal of Advanced Nursing: Literature review. Journal of Advanced Nursing, 55(3), 330-341. https://doi.org/10.1111/j.1365-2648.2006.03915.x